XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte Biotech Investing
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003 Pharmaceutical Investing
Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA Pharmaceutical Investing
Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine Pharmaceutical Investing
Galectin Therapeutics Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA Biotech Investing
Scilex Announces Pricing and Availability of ZTlido for the Commercial Launch of its First Product in October of 2018 Pharmaceutical Investing
